Skip to main content

Deficiency of vitamin B12 and its relation with neurological disorders: a critical review

Abstract

B12 is an essential vitamin for human body which reduces the chances of neurological diseases, birth defects, and chronic disorders. It is a vital micro-nutrient for maintaining the brain health. This review sorts out some causes of vitamin B12 (B12) deficiency and develops its link with neurological disorders. The portals include PubMed, Google Scholar, Directory of Open Access Journals (DOAJ), Pak MediNet, and Science Direct were search for literature retrieval. Study of literature revealed that deficiency of this vitamin occurs primarily due to insufficient dietary intake which results in a group of neurological symptoms in adults as well as infants. These neurological disorders include apathy, anorexia, irritability, growth retardation, and developmental regression. It may also involve in delayed myelination or demyelination of neurons. It was concluded that B12 is vital micro-nutrient for healthy brain in children, younger, and elders. Various conditions are responsible for deficiency of B12. A timely and proper supplementation is necessary if it is dietary deficiency.

Introduction

B12 is a water-soluble complex organic compound. It is required for normal development of animals, human beings, and even several microorganisms (Allen, 2004). Body is unable to synthesize in sufficient amount and must be taken in diet. It has a complex structure and contains a metallic ion along with cobalt. Several of its forms exist. However, cobalamin and cyan cobalamin are the most common forms (Andersen et al., 2010). It is synthesized by microorganisms in cows and sheep. In cows, it is transferred to muscle from rumen and other tissues. Human beings get this vitamin from diet consisting of cows flesh (Selhub, 2002). Other nutritional sources are eggs and dairy products. Strict vegetarians develop deficiency of B12 and must take fortified supplements (Black, 2008). Being water-soluble, B12 can flush out from organisms. Further, fat cells or fatty acid unable to stored it. Therefore, daily consumption level or upper intake level (UL) yet to establish (Kanazawa et al., 1983).

Several strong evidences prove that severe B12 deficiency leads to neuropathy or pernicious anemia, ileal resections, and gastrectomy (Dagnelie et al., 1989; Kozyraki et al., 1999). The pernicious anemia is rarely recorded in dietary B12 deficient people except young infants with solely breast feeders or strict vegetarians (Dagnelie et al., 1989).

Forms of B12

If B12 has mineral cobalt, then it is cobalamin (Fyfe et al., 2004). Other forms include methyl cobalamin, deoxyadenosylcobalamin, hydroxocobalamin, and cyanocobalamin. Methyl cobalamin is the most active circulating form in humans and present in nutrition supplements. The body needs to convert this form into either methyl cobalamin or 5-deoxyandenosylcobalamin for its absorption (Briani et al., 2013) (Fig. 1).

Fig. 1
figure1

Convertible forms of vitamin B12 in human physiology

Absorption and metabolism

Digestive system absorbs the cobalamin in three steps:

  1. 1.

    Food protein bounded with B12 is released by the action of gastric acid and pepsin and then taken by transcobalamin I (TCI) and then transported to the duodenum (Moestrup & Verroust, 2001).

  2. 2.

    An alkalizing action performed by pancreatic juices with its enzymes (tripsin, chymotrypsin and elastase) breakdown TCI and liberates cobalamin which joins an intrinsic factor (IF). The synthesis of this factor is carried out in parietal cells in the fundus and cardia of the stomach (Christensen & Birn, 2002; Nexo, 1998). It protects cobalamin and carries cubilin in the ileum.

  3. 3.

    Finally, IF-cobalamin complex shows tendency of binding towards cubilin and then taken up the enterocyte by a calcium-dependent passive transport mechanism system (Chanarin et al., 1978).

The chemical structure of cobalamin shows 1 cobalt atom with 4 pyrrole rings in corrin ring as a central part (Eschenmoser, 1988). Cobalamin has different names due to attached radical. For example, it is cyanocobalamin when attach atom is cyano radical, a highly stable compound. When attaches with adenosyland methyl radical, it is called adenosylcobalamin and methylcobalamin.

Cobalamin absorbed in ileum through cubilin receptor. It is a complex structure of cubilin, proteins—megalin and amnion associated transmembrane protein (AMN) (Nykjaer et al., 2001). Its molecular weight is 460 kDa and exists in proximal tubule. Absorption is carried out at acidic pH at 5.4. Three cobalamin-binding proteins (ascobalophilins), one carrier haptocorrin, or R protein are associated with absorption and recorded in mature granulocytes and monocytes of precursor cells. It is also observed in the saliva, bile, gastric acid, and breast milk secreted by exocrine epithelial cells (Nykjaer et al., 2001) (Fig. 2).

Fig. 2
figure2

Metabolic pathway of vitamin B12 in human body (modified from Selladurai et al. (2017))

Importance of B12

Being micronutrient, B12 is essential for production and maintenance of RBCs and myelination of nerve cells. It also aids in neurotransmitter, DNA, and RNA production. Many people supplement the B12 via injections on a regular basis to a boost in energy level (de Benoist, 2008) (Fig. 3).

Fig. 3
figure3

Some key functions of vitamin B12 in human physiology

Pathophysiology

As origin of B12 is the bacterial synthesis in rumen of ruminant animals therefore, meat is a good source. After entry in the stomach, B12 is bounded to R-binders (protein) secreted by the salivary glands and stomach. While passing through the small intestine, pancreatic enzymes cleave B12 form R-binder and bound with intrinsic factor (IF). This IF is secreted by the parietal cells and glycoprotein in nature. B12 is then transported to plasma and bind with transcobalamin intracellularly. The absorption is very efficient in the distal ileum (enterohepatic recirculation). It takes many years a vegan person to deplete as long as his intestinal and hepatobiliary systems are intact. The liver is the largest storage site, and total body pool is about 2500 μg in normal adult.

Strict vegetarians are at high risk of deficiency. However, bacterial and insect contamination in food stuffs protects them to some extant against deficiency. Contamination of ruminant feces in vegetables and drinking water could also serve as a source of dietary B12 for vegetarians or economically poor areas of the world. Specific symptoms of deficiency are presented in Fig. 4.

Fig. 4
figure4

Signs and symptoms in B12 Deficiency

Causes of deficiencies

Deficiency exists among all age, economic classes, races, and sexes. It is the most common nutritional deficiency in the USA (Allen, 2004). Diagnosis at early stage and its remedy is extremely necessary to prevent neurologic disorders, poor outcomes, or premature death (de Benoist, 2008). Some causes of deficiencies are as follows.

Pernicious anemia

Pernicious anemia is the most common cause of B12 deficiency. It is an auto-immune condition which affects 1 in 10,000 population. In this disease, an intrinsic factor required for absorption of B12 from food into the gastrointestinal tract is absent. However, the condition is common among people of over 60, in women, with family history and some autoimmune conditions including Addison’s disease and vitiligo (Reid, 2010).

Autoimmune AG develops in condition when body produces antibodies against healthy stomach cells normally produced against viruses and bacteria. People with autoimmune AG target acidic juices producing healthy stomach cells. Intrinsic factor is also under influence of these antibodies and causes pernicious anemia. Deficiency of B12 make impossible to produce enough healthy RBCs (Reynolds et al., 1993). B12 deficiency also occurs in abdominal tuberculosis when there is involvement of the terminal ileum.

Malabsorption

Absence or deficiency of HCl, pepsin, and haptocorrin (HC), R-protein or factor makes it difficult to B12 to extract from food in the stomach and transport intact in the small intestine (Wrong et al., 1981). Further, disorder in the stomach lining, and insufficient saliva and gastric juice also arise these circumstances (Katz et al., 1974). Absorption in the intestine requires intrinsic factor, pancreatic juice, and calcium. Deficiency or absence of any of these factors causes malabsorption (Veeger et al., 1962).

Rare genetic disorder can result in absence of transcobalamin. This leads to inadequacy of B12 for cells. Sometimes, transcobalaminis sufficiently available; however, large amount of biologically inactive B12 analogs binds with it and prevents actual vitamin B12 from binding to transcobalamin. Therefore, a deficiency can develop in spite of good absorption (Booth & Heath, 1962). Genetic disorder can also alter the structure and production of specific enzymes which changes B12 in coenzyme. In this step, genetic disorder prevents necessary metabolic processes from taking place in cells (Hakami et al., 1971) (Fig. 5).

Fig. 5
figure5

Causes and particulars of B12 malabsorption from digestive tract

Vegan diet

Some religious belief can also cause the deficiency. For example, the vegetarian people who do not eat the meat due to religious reasons have risk of B12 deficiency. Vegans usually have low B12 but higher folate concentrations. Half of the vegans having B12 deficiencies have a higher risk of developing clinical symptoms (Herrmann & Geisel, 2002).

Diagnosis

Diagnosis can be performed in a number of ways. A typical method is screening the patients for serum B12 level. However, the level of methylmalonic acid in serum is measured if the suspicion is strong and B12 level is low normal (Budson & Solomon, 2015).

Treatment of deficiency

Supplementation with B12 is conducted to treat deficiency either orally (if vegan diet) or parenterally (if atrophy gastritis). Monitoring is necessary with treatment, and cognition should return to normal (Budson & Solomon, 2015).

Neurological disorders

People from all age groups are suffered with depression, severe anxiety, and psychiatric disorders. These patients are prescribed costly psychotropic drugs, narcotics, or benzodiazepines; however, actually the problem is B12 deficiency (Selhub et al., 2008). Some diseases caused by B12 deficiency are as follows.

Myeloneuropathy

Myelopathy caused by lower concentration of B12 is subacute combined degeneration because symptoms develop slowly. It is also “combined” because multiple neurological symptoms develop in this degeneration (Aaron et al., 2005). The posterior column of spinal card is major part to damage. This part is the most important which controls and carries sensory information regarding vibrations, light touch, and position to brain. As a consequence of B12 deficiency, DNA is also damaged and leads to neurological damage; therefore, people feel numbness tingling (Román et al., 2002). The autonomic nerves can also be target of damage as these nerve fibers run through the spinal cord. In addition, it may also diminish vision and sense of smell. People may develop dementia in the final stage (Selhub et al., 2008).

Demyelination

B12 has important immune modulatory and neurotrophic effects in addition to role as cofactor in myelination (Miller et al., 2005). B12 deficiency and multiple sclerosis (MS) both have pathophysiological condition like inflammatory and neurodegenerative disorder. Resemblances in clinical findings and MRI presentation, it is very difficult to diagnose between B12 deficiency and MS. Further, decrease in levels of B12 demonstrated in patient with multiple sclerosis (Miller et al., 2005).

Alzheimer’s disease

If a person feels behavior changes and agitation, it could be symptoms of Alzheimer disease. However, it can also be related to low levels of vitamin B12. Deficiency produces large amount of mononuclear IL-6 in the peripheral blood. It is associated with slowly onset of Alzheimer disease which worse over time (Burns et al., 2009). In 60 to 70% cases, it causes dementia. The early symptom is short-term memory loss (Politis et al., 2010). The transcobalamin or holo TC level is associated with cognitive function and Alzheimer’s disease (Renvall et al., 1989). However, this association with Alzheimer’s disease was only present in patients with high homocysteine level. Further, low level of cobalamin in tissue or an interaction between homocysteine and cobalamin could also be the reason (Refsum, 2001). In Alzheimer’s disease, dementia is caused by low level of B12 in serum of elderly persons (Osimani et al., 2005).

Atrophy or Brain shrinkage

The term atrophy means loss or shrinkage of cells. In brain atrophy, neurons and their connections waste away and cause the brain shrinkage than normal size. Infants with atrophy were diagnosed with vitamin B12 deficiency (de Jager, 2014). Other risk factor is homocysteine (Hcy) accumulation in plasma (Hogervorst et al., 2002; McCaddon et al., 2001). Conversion of Hcy to its metabolites, i.e., S-adenosyl methionine and glutathione depends on three vitamins as cofactors. These vitamins include B9 (methyl folate), B12 (cobalamin), and B6 (pyridoxine) (Morris et al., 2005; Refsum, 2001; Refsum et al., 2006). Suboptimal supply of B-vitamin in diet, remethylation of Hcy through methionine synthase is lowered and Hcy in plasma rise (Birch et al., 2009).

Sub-acute combined degeneration

Sub-acute combined degeneration (SCD) is progressive degenerative disorder which targets the spinal cord. It may also affect the nerves of the eyes and peripheral nervous system (Reynolds et al., 1993). B12 deficiency is the cause of SCD. In this disorder, damage to myelin sheath is occurred and followed by degeneration in axons (Victor & Lear, 1956). Initial symptoms are numbness, clumsy movements, and tingling sensation. Other symptoms are visual problems, weakness, cognitive disturbances, erectile dysfunctions, and abnormal reflexes in the bladder (Morris et al., 2005). Early B12 supplementation gives better results. However, delay can reduce the chance of recovery and lost the functionality (Werder, 2010).

Vascular complications

Elevated level of homocysteine in blood could be the risk factor for stroke along with other vascular complications (Tomkin et al., 1971). Quinlivan et al. (2002) demonstrated folic acid, and B12 fortified food could lower homocysteine levels and reduced the risk of vascular disease.

Neuropsychiatric abnormalities

Psychiatric problems are associated with B12 deficiency in adults between the ages of 40–90 years and rarely affect people of younger age (Stanger et al., 2003). The psychiatric manifestations include cognitive changes (like memory decline), depression, delusions, hallucinations, and dementia (Engelborghs et al., 2004). The mechanisms behind are instable production of neurotransmitters and elevated homocysteine and methylmalonic acid (MMA) level in B12 deficient people. Screening and supplementation of B12 should be considered if there is no other obvious cause of a psychiatric disorder (Zengin et al., 2009).

Infantile seizures

During infancy, epileptic seizures have varied clinical presentations. It may have different outcomes according to etiology. B12 is also a rear cause of infantile seizures. Infants have the most common symptoms of B12 deficiency like feeding difficulties, seizures, growth retardation, megaloblastic anemia, developmental delay, hypotonia, microcephaly, lethargy, involuntary movements, irritability, and cerebral atrophy. Rarely, involuntary movements and seizures are the initial symptoms of deficiency. Involuntary movements are also reported after start of B12 supplementation in few cases. However, no information is present in literature regarding seizures (Benbir et al., 2007).

Poor fetal brain and cognitive development

Vitamin B12 and folate play a key role in fetus brain development. Both are also crucial for myelination in new born baby in first 2 years and till puberty (Hellegers et al., 1957). As B12 deficiency constrained in myelination, child develops varied cognitive and intellectual problems depending upon the area of the nervous system affected (Graber et al., 1971). Deficiency of both in pregnant women needs supplements in order to prevent neurological disorders in fetus (Wilson et al., 1999). Elderly people face problem to absorb this vitamin from food sources so its deficiency can be fulfilled with supplements (Rosenberg, 2005). Vegans also face deficiency which may be restored by supplements. Minimum per take uptake to prevent the deficiency provided in Table 1 (IOM, 1998).

Table 1 Age-wise requirement of vitamin B12 (microgram) in human (IOM 1998)

Conclusion

It was concluded that B12 is vital micro-nutrient for maintaining healthy brain in children, youngers, and elders. Various conditions are responsible for B12 deficiency. A timely and proper supplementation is necessary if it is dietary deficiency. This supplementation can prevent the damage to nervous system. Deficiency may leads to cognitive decline and vascular risk factors in neuropsychiatric disorders. Therefore, recognition and early management reverse deficiency state. Some behavioral or psychological disorders are related to dementia and depression which can be improved with B12 supplementation.

Availability of data and materials

Data sharing not applicable to this article

Abbreviations

B12:

Vitamin B12

DOAJ:

Directory of Open Access Journals

HC:

Haptocorrin

Hcy:

Homocysteine

IF:

Intrinsic factor

IOM:

Institute of Medicine

MRI:

Magnetic resonance imaging

MS:

Multiple sclerosis

SCD:

Sub-acute combined degeneration

TCI:

Transcobalamin I

UL:

Upper intake level

References

  1. Aaron, S., Kumar, S., Vijayan, J., Jacob, J., Alexander, M., & Gnanamuthu, C. (2005). Clinical and laboratory features and response to treatment in patients presenting with vitamin B12 deficiency-related neurological syndromes. Neurology India, 53(1), 55.

    Article  CAS  Google Scholar 

  2. Allen, L. H. (2004). Folate and vitamin B12 status in the Americas. Nutrition reviews, 62, S29–S33.

    Article  Google Scholar 

  3. Andersen, C. B. F., Madsen, M., Storm, T., Moestrup, S. K., & Andersen, G. R. (2010). Structural basis for receptor recognition of vitamin-B 12–intrinsic factor complexes. Nature, 464(7287), 445.

    Article  CAS  Google Scholar 

  4. Benbir, G., Uysal, S., Saltik, S., Zeybek, C. A., Aydin, A., Dervent, A., & Yalcinkaya, C. (2007). Seizures during treatment of vitamin B12 deficiency. Seizure, 16(1), 69–73.

    Article  CAS  Google Scholar 

  5. Birch, C. S., Brasch, N. E., McCaddon, A., & Williams, J. H. (2009). A novel role for vitamin B12: cobalamins are intracellular antioxidants in vitro. Free Radical Biology and Medicine, 47(2), 184–188.

    Article  CAS  Google Scholar 

  6. Black, M. M. (2008). Effects of vitamin B12 and folate deficiency on brain development in children. Food and nutrition bulletin, 29(2_suppl1), S126-S131.

  7. Booth, C., & Heath, J. (1962). The effect of E. coli on the absorption of vitamin B12. Gut, 3(1), 70–73.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Briani, C., Dalla Torre, C., Citton, V., Manara, R., Pompanin, S., Binotto, G., & Adami, F. (2013). Cobalamin deficiency: clinical picture and radiological findings. Nutrients, 5(11), 4521–4539.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Budson, A. E., & Solomon, P. R. (2015). Memory loss, Alzheimer’s disease, and dementia e-book: A practical guide for clinicians: Elsevier Health Sciences.

    Google Scholar 

  10. Burns, A., Bernabei, R., Bullock, R., Jentoft, A. J. C., Frölich, L., Hock, C., … Wimo, A. (2009). Safety and efficacy of galantamine (Reminyl) in severe Alzheimer's disease (the SERAD study): a randomised, placebo-controlled, double-blind trial. The Lancet Neurology, 8(1), 39–47.

    Article  CAS  Google Scholar 

  11. Chanarin, I., Muir, M., Hughes, A., & Hoffbrand, A. (1978). Evidence for intestinal origin of transcobalamin II during vitamin B12 absorption. Br Med J, 1(6125), 1453–1455.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Christensen, E. I., & Birn, H. (2002). Megalin and cubilin: multifunctional endocytic receptors. Nature reviews Molecular cell biology, 3(4), 258.

    Article  CAS  Google Scholar 

  13. Dagnelie, P. C., van Staveren, W. A., Vergote, F. J., Dingjan, P. G., Van Den Berg, H., & Hautvast, J. (1989). Increased risk of vitamin B-12 and iron deficiency in infants on macrobiotic diets. The American journal of clinical nutrition, 50(4), 818–824.

    Article  CAS  Google Scholar 

  14. de Benoist, B. (2008). Conclusions of a WHO Technical Consultation on folate and vitamin B12 deficiencies. Food and nutrition bulletin, 29(2_suppl1), S238-S244.

  15. de Jager, C. A. (2014). Critical levels of brain atrophy associated with homocysteine and cognitive decline. Neurobiology of aging, 35, S35–S39.

    Article  CAS  Google Scholar 

  16. Engelborghs, S., Vloeberghs, E., Maertens, K., Mariën, P., Somers, N., Symons, A., … Goeman, J. (2004). Correlations between cognitive, behavioural and psychological findings and levels of vitamin B12 and folate in patients with dementia. International journal of geriatric psychiatry, 19(4), 365–370.

    Article  Google Scholar 

  17. Eschenmoser, A. (1988). Vitamin B12: experiments concerning the origin of its molecular structure. Angewandte Chemie International Edition in English, 27(1), 5–39.

    Article  Google Scholar 

  18. Fyfe, J. C., Madsen, M., Højrup, P., Christensen, E. I., Tanner, S. M., de la Chapelle, A., … Moestrup, S. K. (2004). The functional cobalamin (vitamin B12)–intrinsic factor receptor is a novel complex of cubilin and amnionless. Blood, 103(5), 1573–1579.

    Article  CAS  Google Scholar 

  19. Graber, S. E., Scheffel, U., Hodkinson, B., & McIntyre, P. A. (1971). Placental transport of vitamin B 12 in the pregnant rat. The Journal of clinical investigation, 50(5), 1000–1004.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Hakami, N., Neiman, P. E., Canellos, G. P., & Lazerson, J. (1971). Neonatal megaloblastic anemia due to inherited transcobalamin II deficiency in two siblings. New England Journal of Medicine, 285(21), 1163–1170.

    Article  CAS  Google Scholar 

  21. Hellegers, A., Okuda, K., Nesbitt Jr., R. E., Smith, D. W., & Chow, B. F. (1957). Vitamin B12 absorption in pregnancy and in the newborn. The American journal of clinical nutrition, 5(3), 327–331.

    Article  CAS  Google Scholar 

  22. Herrmann, W., & Geisel, J. (2002). Vegetarian lifestyle and monitoring of vitamin B-12 status. Clinica chimica acta, 326(1-2), 47–59.

    Article  CAS  Google Scholar 

  23. Hogervorst, E., Ribeiro, H. M., Molyneux, A., Budge, M., & Smith, A. D. (2002). Plasma homocysteine levels, cerebrovascular risk factors, and cerebral white matter changes (leukoaraiosis) in patients with Alzheimer disease. Archives of neurology, 59(5), 787–793.

    Article  Google Scholar 

  24. IOM. (1998). Institute of Medicine Food and Nutrition Board on the Scientific Evaluation of Dietary Reference Intakes Dietary reference intakes for thiamin, riboflavin, niacin, vitamin B6, folate, vitamin B12, pantothenic acid, biotin, and choline: National Academies Press (US).

  25. Kanazawa, S., Herbert, V., Herzlich, B., Drivas, G., & Manusselis, C. (1983). Removal of cobalamin analogue in bile by enterohepatic circulation of vitamin B12. The Lancet, 321(8326), 707–708.

    Article  Google Scholar 

  26. Katz, M., Mehlman, C. S., & Allen, R. H. (1974). Isolation and characterization of an abnormal human intrinsic factor. The Journal of clinical investigation, 53(5), 1274–1283.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Kozyraki, R., Fyfe, J., Kristiansen, M., Gerdes, C., Jacobsen, C., Cui, S., … Krahe, R. (1999). The intrinsic factor–vitamin B 12 receptor, cubilin, is a high-affinity apolipoprotein AI receptor facilitating endocytosis of high-density lipoprotein. Nature medicine, 5(6), 656.

    Article  CAS  Google Scholar 

  28. McCaddon, A., Hudson, P., Davies, G., Hughes, A., Williams, J. H., & Wilkinson, C. (2001). Homocysteine and cognitive decline in healthy elderly. Dementia and geriatric cognitive disorders, 12(5), 309–313.

    Article  CAS  Google Scholar 

  29. Miller, A., Korem, M., Almog, R., & Galboiz, Y. (2005). Vitamin B12, demyelination, remyelination and repair in multiple sclerosis. Journal of the neurological sciences, 233(1-2), 93–97.

    Article  CAS  Google Scholar 

  30. Moestrup, S. K., & Verroust, P. J. (2001). Megalin-and cubilin-mediated endocytosis of protein-bound vitamins, lipids, and hormones in polarized epithelia. Annual review of nutrition, 21(1), 407–428.

    Article  CAS  Google Scholar 

  31. Morris, M. C., Evans, D. A., Bienias, J. L., Tangney, C. C., Hebert, L. E., Scherr, P. A., & Schneider, J. A. (2005). Dietary folate and vitamin B12 intake and cognitive decline among community-dwelling older persons. Archives of neurology, 62(4), 641–645.

    Article  Google Scholar 

  32. Nexo, E. (1998). Cobalamin binding proteins. Vitamin B, 12, 459–475.

    Google Scholar 

  33. Nykjaer, A., Fyfe, J. C., Kozyraki, R., Leheste, J.-R., Jacobsen, C., Nielsen, M. S., . . . Moestrup, S. K. (2001). Cubilin dysfunction causes abnormal metabolism of the steroid hormone 25 (OH) vitamin D3. Proceedings of the National Academy of Sciences, 98(24), 13895-13900.

    Article  CAS  Google Scholar 

  34. Osimani, A., Berger, A., Friedman, J., Porat-Katz, B.-S., & Abarbanel, J. M. (2005). Neuropsychology of vitamin B1 2 deficiency in elderly dementia patients and control subjects. Journal of geriatric psychiatry and neurology, 18(1), 33–38.

    Article  Google Scholar 

  35. Politis, A., Olgiati, P., Malitas, P., Albani, D., Signorini, A., Polito, L., … Stamouli, E. (2010). Vitamin B12 levels in Alzheimer’s disease: association with clinical features and cytokine production. Journal of Alzheimer's Disease, 19(2), 481–488.

    Article  CAS  Google Scholar 

  36. Quinlivan, E., McPartlin, J., McNulty, H., Ward, M., Strain, J., Weir, D., & Scott, J. (2002). Importance of both folic acid and vitamin B12 in reduction of risk of vascular disease. The Lancet, 359(9302), 227–228.

    Article  CAS  Google Scholar 

  37. Refsum, H. (2001). Folate, vitamin B12 and homocysteine in relation to birth defects and pregnancy outcome. British Journal of Nutrition, 85(S2), S109–S113.

    Article  CAS  Google Scholar 

  38. Refsum, H., Nurk, E., Smith, A. D., Ueland, P. M., Gjesdal, C. G., Bjelland, I., … Vollset, S. E. (2006). The Hordaland Homocysteine Study: a community-based study of homocysteine, its determinants, and associations with disease. The Journal of nutrition, 136(6), 1731S–1740S.

    Article  CAS  Google Scholar 

  39. Reid, T. R. (2010). The healing of America: A global quest for better, cheaper, and fairer health care: Penguin.

    Google Scholar 

  40. Renvall, M. J., Spindler, A. A., Ramsdell, J. W., & Paskvan, M. (1989). Nutritional status of free-living Alzheimer’s patients. The American journal of the medical sciences, 298(1), 20–27.

    Article  CAS  Google Scholar 

  41. Reynolds, E., Bottiglieri, T., Laundy, M., Stern, J., Payan, J., Linnell, J., & Faludy, J. (1993). Subacute combined degeneration with high serum vitamin B12 level and abnormal vitamin B12 binding protein: new cause of an old syndrome. Archives of neurology, 50(7), 739–742.

    Article  CAS  Google Scholar 

  42. Román, G. C., Erkinjuntti, T., Wallin, A., Pantoni, L., & Chui, H. C. (2002). Subcortical ischaemic vascular dementia. The Lancet Neurology, 1(7), 426–436.

    Article  Google Scholar 

  43. Rosenberg, I. H. (2005). Science-based micronutrient fortification: which nutrients, how much, and how to know? : Oxford University Press.

    Google Scholar 

  44. Selhub, J. (2002). Folate, vitamin B12 and vitamin B6 and one carbon metabolism. The journal of nutrition, health & aging, 6(1), 39–42.

    CAS  Google Scholar 

  45. Selhub, J., Jacques, P. F., Dallal, G., Choumenkovitch, S., & Rogers, G. (2008). The use of blood concentrations of vitamins and their respective functional indicators to define folate and vitamin B12 status. Food and nutrition bulletin, 29(2_suppl1), S67-S73.

  46. Stanger, O., Herrmann, W., Pietrzik, K., Fowler, B., Geisel, J., Dierkes, J., & Weger, M. (2003). DACH-LIGA homocystein (German, Austrian and Swiss Homocysteine Society): consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations. Clinical chemistry and laboratory medicine, 41(11), 1392–1403.

    CAS  PubMed  Google Scholar 

  47. Tomkin, G., Hadden, D., Weaver, J., & Montgomery, D. (1971). Vitamin-B12 status of patients on long-term metformin therapy. Br Med J, 2(5763), 685–687.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Veeger, W., Abels, J., Hellemans, N., & Nieweg, H. (1962). Effect of sodium bicarbonate and pancreatin on the absorption of vitamin B12 and fat in pancreatic insufficiency. New England Journal of Medicine, 267(26), 1341–1344.

    Article  CAS  Google Scholar 

  49. Victor, M., & Lear, A. A. (1956). Subacute combined degeneration of the spinal cord: current concepts of the disease process. Value of serum vitamin B12 determinations in clarifying some of the common clinical problems. The American journal of medicine, 20(6), 896–911.

    Article  CAS  Google Scholar 

  50. Werder, S. F. (2010). Cobalamin deficiency, hyperhomocysteinemia, and dementia. Neuropsychiatric disease and treatment, 6, 159.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Wilson, A., Platt, R., Wu, Q., Leclerc, D., Christensen, B., Yang, H., … Rozen, R. (1999). A common variant in methionine synthase reductase combined with low cobalamin (vitamin B 12) increases risk for spina bifida. Molecular genetics and metabolism, 67(4), 317–323.

    Article  CAS  Google Scholar 

  52. Wrong, O. M., Edmonds, C., & Chadwick, V. (1981). The large intestine: Its role in mammalian nutrition and homeostasis: Wiley New York.

    Google Scholar 

  53. Zengin, E., Sarper, N., & Çakı Kılıç, S. (2009). Clinical manifestations of infants with nutritional vitamin B12 deficiency due to maternal dietary deficiency. Acta paediatrica, 98(1), 98–102.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The authors acknowledge Dr. Muhammad Wajid University of Okara and Prof. Dr. Naureen Aziz Qureshi for their valuable suggestion in improving this review.

Funding

This study review does not receive any funding in any form. This work is the product of authors own efforts.

Author information

Affiliations

Authors

Contributions

AN and NNK search the different data base for literature retrieval. MSK arrange, compile the format, and handle the correspondence. HN and SS selected the literature and finalize the manuscript. The authors read and approved the final manuscript.

Corresponding author

Correspondence to Muhammad Saleem Khan.

Ethics declarations

Ethics approval and consent to participate

This study was approved by ethical review board of the university.

Consent for publication

Not applicable

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Nawaz, A., Khattak, N.N., Khan, M.S. et al. Deficiency of vitamin B12 and its relation with neurological disorders: a critical review. JoBAZ 81, 10 (2020). https://doi.org/10.1186/s41936-020-00148-0

Download citation

Keywords

  • Deficiency
  • B12
  • Disorders
  • Neurological
  • Review